Search

China pioneers biosecurity report against ASF

Boehringer Ingelheim compiles data from 1,000 swine farms into the first market report on biosecurity. Document sheds light on livestock management and contributes to the fight against African swine fever.

George Okafo

My career challenge at Boehringer Ingelheim by George Okafo. Read it now!

bix_facilitates_global_partnerships

BI X focuses on partnerships to speed up the development of digital healthcare solutions

PREVEXXION® RN: Marek’s disease vaccine available in EU UK

Boehringer Ingelheim is pleased to announce the launch of the next generation of Marek’s disease vaccines is now available in the EU.

digital_leader_award_2020

Boehringer Ingelheim wins first place in the "STRATEGY" category of the Digital Leader Award

Monoclonal antibodies Boehringer Ingelheim and Invetx

Boehringer Ingelheim and Invetx announce collaboration to discover, develop and commercialize novel veterinary monoclonal antibody biotherapeutics

Boehringer receives SBTi validation for CO2 reduction targets

Boehringer Ingelheim receives SBTi validation for CO2 reduction targets

Data science, agile working, UX design: our evolving IT careers

Meet our IT colleagues working in the fields of user experience, data science and agile development

India: Many positive developments for the population

A conversation with interim country manager Sandip Agrawal about a young and growing country

Supporting grooms in equestrian sports

Find out how one organization can change the lives of those who dedicate their careers to horse care.

Edda Dankmeyer

Edda Dankmeyer is our Lead of Sustainable Development Communications. She tells us where her passion for sustainability comes from, why she joined us, and how sustainable development can be a key differentiator for the company.

FreVAX smartphone application piglet vaccination

New FreVAX™ smartphone application brings piglet vaccination to another level

Positive opinion Ingelvac CircoFLEX and Ingelvac PRRSFLEX EU

Boehringer Ingelheim receives positive opinion for the combined use of Ingelvac CircoFLEX® and Ingelvac PRRSFLEX EU® in the EU

European_Commission_approves_nintedanibSSc-ILD

Nintedanib is approved as the first and only treatment of systemic sclerosis-associated interstitial lung disease

clinical_collaboration_with_Mirati

Boehringer Ingelheim and Mirati are teaming up in a clinical collaboration to evaluate the combination of the SOS1::pan-KRAS and the selective G12C inhibitor.

Aservo EquiHaler wins Pharmapack Award 2021

Boehringer Ingelheim’s Aservo® EquiHaler® is recognized in the 2021 Pharmapack Awards

Veterinarians go beyond: animal care and veterinary medicine

We surveyed over 1000 veterinarians from six countries. Did you know that only 49% of respondents think that the veterinary profession is appreciated?

Global Top Employer 2023

Rabies wildlife 5 things to know

Rabies in wildlife - 5 things to know to protect yourself and your pet

Resizing our Carbon Footprint

The ecological balance of the world is at a tipping point.

Partnering with Lifebit to detect global disease outbreaks

Boehringer Ingelheim partners with Lifebit to detect global infectious disease outbreaks

global-top-employer

For the first time, Boehringer Ingelheim receives the award as a Global Top Employer as well as individual awards in 27 countries.

PRRS vaccine celebrates 25 years in Europe

Boehringer Ingelheim celebrates 25 years to combat PRRS in Europe

Agreement-to-acquire-Labor-Dr.-Merk

Boehringer Ingelheim to acquire Labor Dr. Merk & Kollegen to strengthen its next generation cancer immunology program

New indications NexGard, NexGard SPECTRA and Broadline

New therapeutic indications for NexGard®, NexGard SPECTRA® and Broadline® approved by EMA

About Us

Human Health

Animal Health

Science & Innovation

Partnering

Careers